NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 12, 2026 — Health IT companies push for consistent AI regulations as conflicting state rules threaten innovation and create unequal patient care standards across the United States.
January 12, 2026 — Health IT companies push for consistent AI regulations as conflicting state rules threaten innovation and create unequal patient care standards across the U.S.
January 12, 2026 — DaCapo Brainscience appoints new CEO, CTO, and CSO to advance small-molecule therapies for neurodegenerative diseases using proprietary discovery platform targeting Parkinson's disease progression.
January 12, 2026 — Voyageur Pharmaceuticals acquires exclusive iodine extraction technology, the Mueller Process, to enhance cost efficiency and supply security in the multi-billion-dollar contrast media market.
January 12, 2026 — New research reveals TV shows misrepresent CPR, showing younger, white recipients in wrong locations. These inaccurate portrayals may reinforce real-world disparities in who receives lifesaving help.
January 12, 2026 — SaveRxCanada.to offers bulk Ozempic from India at ~$252/pen, saving patients up to $8,000/year vs. U.S. prices. Requires valid prescription.
January 12, 2026 — Dr. Roseann Capanna-Hodge's Dysregulated Kids podcast surpasses 2M downloads, offering science-backed parenting help for emotional regulation at Podfest Expo.
January 12, 2026 — NavioMD launches clinician-guided telehealth platform emphasizing structured care pathways and ongoing provider support. Learn how this approach addresses evolving patient expectations for digital healthcare.
January 10, 2026 — Tabor Dental Associates in Hendersonville, TN offers advanced dental care with a focus on patient comfort, led by Dr. Jayson Tabor. Services include implants, cosmetic dentistry, and sedation options.
January 10, 2026 — Smile Line Dentistry in Antioch offers comprehensive dental services with advanced technology and experienced dentists. Learn about their patient-focused care for all ages.
January 10, 2026 — Stonegate Capital Partners initiates coverage on NeOnc Technologies (NASDAQ: NTHI), highlighting their intranasal CNS therapies and NEO100's 2026 Phase 2a readout.
January 9, 2026 — HeartBeam receives FDA clearance for portable 3D ECG technology that converts heart signals to 12-lead format for remote cardiac monitoring, ranking second globally in portable cardiac diagnostics innovation.
January 9, 2026 — Soligenix reaches Phase 3 milestone for HyBryte in CTCL with 48% response rate. Zacks maintains $25 valuation, highlighting potential in rare disease treatments and vaccine development.
January 9, 2026 — HeartBeam's FDA-cleared 3D ECG technology transforms remote cardiac monitoring with portable 12-lead ECG synthesis, ranking second globally in portable cardiac diagnostics innovation.
January 9, 2026 — Oncotelic Therapeutics advances nanoparticle cancer treatment with Sapu-003, enhancing drug delivery through innovative nanotechnology that improves bioavailability and tumor targeting for better patient outcomes.
January 9, 2026 — BioUtah announces participation in J.P. Morgan 44th Annual Healthcare Conference, representing Utah's 1,600+ life sciences companies in medical devices, biotech & digital health.
January 9, 2026 — Hong Kong researchers develop silica biomaterial that could revolutionize cancer immunotherapy by improving efficacy and reducing costs for solid tumor treatment.
January 9, 2026 — Sisel International launches EMPOWER 2026 initiative focusing on holistic wellness beyond products. Learn about this values-driven approach to personal development and long-term well-being in the evolving wellness industry.
January 9, 2026 — TG Orthodontics earns Monmouth Magazine's 2026 Top Dentist award, recognized by peers for exceptional orthodontic care in Monmouth County. Learn more about their services.
January 8, 2026 — LIXTE Biotechnology expands ovarian cancer trial with MD Anderson & GSK, doubling enrollment to test LB-100 with Dostarlimab. Data expected 2026 from innovative cancer treatment approach.